Windtree Therapeutics, Inc. (WINT) DCF Valuation

Windtree Therapeutics, Inc. (WINT) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Windtree Therapeutics, Inc. (WINT) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Designed for accuracy, our Windtree Therapeutics, Inc. (WINT) DCF Calculator empowers you to assess Windtree Therapeutics' valuation using real-world financial data and offers complete flexibility to modify all essential parameters for enhanced projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .2 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 -100 0 0 0 -25 -25 -25 -25 -25
EBITDA -25.9 -31.8 -76.6 -39.5 -20.2 .0 .0 .0 .0 .0
EBITDA, % -13064.65 100 100 100 100 60 60 60 60 60
Depreciation 1.1 .6 .9 1.1 .1 .0 .0 .0 .0 .0
Depreciation, % 561.62 100 100 100 100 100 100 100 100 100
EBIT -27.0 -32.4 -77.5 -40.5 -20.2 .0 .0 .0 .0 .0
EBIT, % -13626.26 100 100 100 100 60 60 60 60 60
Total Cash 22.6 16.9 22.3 6.2 4.3 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 0 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 0 100 100 100 100 80 80 80 80 80
Accounts Payable 1.7 1.2 .7 .2 .8 .0 .0 .0 .0 .0
Accounts Payable, % 862.63 100 100 100 100 100 100 100 100 100
Capital Expenditure -.2 -.3 -.3 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % -96.46 100 100 100 100 -19.29 -19.29 -19.29 -19.29 -19.29
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -29.3 -30.2 -67.5 -39.2 -20.2 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -26.7 -30.4 -67.4 -38.6 -19.6 -.8 .0 .0 .0 .0
WACC, % 4.46 4.15 3.89 4.31 4.46 4.26 4.26 4.26 4.26 4.26
PV UFCF
SUM PV UFCF -.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt 13
Equity Value -13
Diluted Shares Outstanding, MM 0
Equity Value Per Share -60.40

What You Will Receive

  • Accurate WINT Financial Data: Pre-filled with Windtree Therapeutics’ historical and projected data for thorough analysis.
  • Completely Customizable Template: Easily adjust key inputs such as revenue growth, WACC, and EBITDA %.
  • Instant Calculations: Watch WINT's intrinsic value update in real-time as you make changes.
  • Expert Valuation Tool: Tailored for investors, analysts, and consultants aiming for precise DCF results.
  • Intuitive Design: User-friendly layout and straightforward instructions suitable for all skill levels.

Key Features

  • Real-Life WINT Data: Pre-filled with Windtree Therapeutics' historical financials and forward-looking projections.
  • Fully Customizable Inputs: Adjust revenue growth, margins, WACC, tax rates, and capital expenditures.
  • Dynamic Valuation Model: Automatic updates to Net Present Value (NPV) and intrinsic value based on your inputs.
  • Scenario Testing: Create multiple forecast scenarios to analyze different valuation outcomes.
  • User-Friendly Design: Simple, structured, and designed for professionals and beginners alike.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review Windtree Therapeutics, Inc.'s (WINT) pre-filled financial data and forecasts.
  3. Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
  5. Step 5: Evaluate the outputs and leverage the findings for your investment decisions.

Why Choose This Calculator for Windtree Therapeutics, Inc. (WINT)?

  • Accuracy: Utilizes real Windtree Therapeutics financial data for precise calculations.
  • Flexibility: Allows users to easily adjust and test various input parameters.
  • Time-Saving: Eliminate the need to create a discounted cash flow model from the ground up.
  • Professional-Grade: Crafted with the expertise and rigor expected at the CFO level.
  • User-Friendly: Intuitive interface designed for users of all financial backgrounds.

Who Should Use Windtree Therapeutics, Inc. (WINT)?

  • Investors: Gain insights into innovative therapies and make informed investment decisions.
  • Healthcare Analysts: Utilize comprehensive data to evaluate the potential of Windtree's pipeline products.
  • Consultants: Easily tailor presentations and reports to highlight Windtree’s advancements in respiratory therapeutics.
  • Biotech Enthusiasts: Enhance your knowledge of cutting-edge treatments and their market implications.
  • Educators and Students: Leverage real-world case studies from Windtree to enrich learning in biotechnology and healthcare courses.

What the Template Contains

  • Pre-Filled Data: Includes Windtree Therapeutics, Inc.'s historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations tailored for (WINT).
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs specific to (WINT).
  • Key Financial Ratios: Analyze Windtree Therapeutics' profitability, efficiency, and leverage metrics.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease for (WINT).
  • Clear Dashboard: Visual representations and tables summarizing key valuation results for (WINT).

No products were found matching.